Dr Reddy’s Laboratories launches generic version of fesoterodine fumarate tablets in US
PTI, Jul 8, 2022, 8:15 PM IST
New Delhi: Dr Reddy’s Laboratories Ltd on Friday said it has launched its generic version of fesoterodine fumarate extended-release tablets used for treating overactive bladder in the US market.
The launch follows the approval granted by the US Food and Drug Administration (USFDA), the pharma company said in a regulatory filing.
The company’s fesoterodine fumarate extended-release tablets are available in 4 mg and 8 mg tablets, each in bottle count sizes of 30. These are the therapeutic generic equivalent of Toviaz, it added.
Citing IQVIA data, Dr Reddy’s said the Toviaz brand had US sales of approximately USD 211 million for the most recent 12 months ended May 2022.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Risk of abnormal blood fat levels increased by about 30 pc during pandemic, finds study
Attention problems could be ‘middleman’ between genetic risk for, experiencing psychosis: Study
Meeting WHO’s sodium recommendations could avert deaths from heart, kidney disease: Study
Meeting WHO’s sodium recommendations could avert deaths from heart, kidney disease: Study
Study finds loss of smell linked with inflammation in 140 conditions, could be early sign of disease
MUST WATCH
Latest Additions
Indian boxer Mandeep Jangra wins WBF’s world title
IOA submits ‘Letter of Intent’ to host 2036 Olympics in India
CBDT allows tax officials to waive or reduce interest due from assessee
Like UP, bring BJP to power in Jharkhand to ‘bulldoze’ mafia: Yogi at Koderma poll rally
Govt asks Wikipedia why it should not be treated as publisher instead of intermediary
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.